CDC Advances Study on Reusable Healthcare Textiles

The Centers for Disease Control and Prevention (CDC) has confirmed that a long-awaited federal study examining reusable healthcare textiles has reached the final stages of internal review, marking a significant development for the linen, uniform and facility services industry.

The CDC’s July 10 response to congressional offices confirms that the agency has completed a draft report and that it is currently undergoing final internal review and clearance. Textile Rental Services Association (TRSA) said commercial laundries supported hospitals and healthcare systems during the COVID-19 pandemic by providing reusable isolation gowns, linens, and other essential healthcare textiles when disposable products became scarce.

TRSA emphasized the critical role reusable healthcare textiles play in protecting healthcare workers, strengthening domestic supply chains, and supporting emergency preparedness. A key priority for the association is securing the release of the National Institute for Occupational Safety and Health (NIOSH) study examining the feasibility and benefits of expanding reusable textiles in healthcare settings.

“The CDC’s confirmation that this study is nearing completion is an important milestone,” said Joe Ricci, TRSA president and CEO. “We appreciate Congress’ continued oversight and look forward to reviewing the findings, which could help strengthen healthcare preparedness and supply-chain resilience.”

The CDC previously indicated the report would be completed in 2024. Industry representatives stressed that healthcare facilities remain heavily dependent on disposable products despite evidence that reusable alternatives can provide equivalent protection while enhancing supply-chain resilience and reducing environmental impacts.

In February 2026, lawmakers formally requested the release of the completed study, sought a timeline for publication, and asked for briefings on findings emerging from the National Academies Workshop on reusable healthcare textiles.

While the CDC stopped short of providing a publication date, the agency indicated that an updated release timeline will be provided once the clearance process is finalized.